Inventor

PLUM LORI A

US103 patents

⚠️ This page may combine multiple inventors who share the name “PLUM LORI A”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

PLUM LORI A

WISCONSIN ALUMNI RES FOUND

(20S)-1α-hydroxy-2-methylene-19-nor-bishomopregnacalciferol and its uses

1α-hydroxy-2-methylene-19-nor-homopregnacalciferol and its uses

(20S)-1α-hydroxy-2-methylene-19-nor-bishomopregnacalciferol and its uses

2-methylene-1α,25-dihydroxy-19,21-dinorvitamin D3 analogs and uses thereof

Vitamin D analog—NEL, methods and uses thereof

19,26,27-trinor-1α,25-dihydroxyvitamin D3 compounds

2α-Methyl and 2β-methyl analogs of 19,26,27-trinor-(20S)-1α-hydroxyvitamin D3 and their uses

2-methylene-19-nor-1alpha-hydroxy-17-ene-homopregnacalciferol and its uses

17,20(E)-dehydro vitamin D analogs and their uses

17,20(Z)-dehydro vitamin D analogs and their uses

1α-hydroxy-2-methylene-19-nor-homopregnacalciferol and its uses

Vitamin D analog—RAK, methods and uses thereof

(20S)-1α-hydroxy-2-methylene-19-nor-bishomopregnacalciferol and its uses

2-Methylene-(20R,25S)-19,27-Dinor-(22E)-Vitamin D Analogs

(20S)-23,23-difluoro-methylene-19-nor-bishomopregnacalciferol-vitamin D analogs

(20R)-23,23-difluoro-2-methylene-19-nor-bishomopregnacalciferol-vitamin D analogs

2-alkylidene-18,19-dinor-vitamin D compounds

2-methylene-19-nor-(20S-24S)-1α,25-dihydroxyvitamin-D2

2-methylene-19-nor-(20S)-1α-hydroxy-trishomopregnacalciferol

(20S)-1α-hydroxy-2-methylene-19-nor-bishomopregnacalciferol and its uses

2-methylene-19,26,27-trinor-(20S)-1α-hydroxyvitamin D3 and its uses

Use of 2-methylene-19-nor-(20S)-1α,25-dihydroxyvitamin D3 to treat secondary hyperparathyroidism

Use of 2-methylene-19-nor-(20S)-1α,25-dihydroxyvitamin D3 to treat secondary hyperparathyroidism

Vitamin D receptor antagonists and their use in treating asthma

2-methylene-(17Z)-17(20)-dehydro-19,21-dinor-vitamin D analogs

Method of extending the dose range of vitamin D compounds

(20S)-1α-Hydroxy-2-Methylene-19-Nor-Bishomopregnacalciferol and its uses

2-methylene-1alpha,25-dihydroxy-18,19,21-trinorvitamin D3 and uses thereof

2-methylene-1α-hydroxy-19,21-dinorvitamin D3 analogs and uses thereof

2-methylene-19-nor-(23S)-25-dehydro-1α-hydroxyvitamin D3-26,23-lactone and 2-methylene-19-nor-(23R)-25-dehydro-1α-hydroxyvitamin D3-26,23-lactone

2-Methylene-18,19-dinor-1α-hydroxy-homopregnacalciferol and its uses

2-methylene-19-nor-(23S)-25-dehydro-1α-hydroxyvitamin D3-26,23-lactone and 2-methylene-19-nor-(23R)-25-dehydro-1α-hydroxyvitamin D3-26,23-lactone

Use of 2-methylene-19-nor-(20S)-1-alpha,25-dihydroxyvitamin D3 to treat secondary hyperparathyroidism in patients previously treated with calcimimetics

17,20(E)-dehydro vitamin D analogs and their uses

2-methylene-19-nor-1α-hydroxy-17-ene-homopregnacalciferol and its uses

Use of 2-methylene-19-nor-(20S)-1α,25-dihydroxyvitamin D3 to prevent secondary hyperparathyroidism or the symptoms thereof

Use of 2-methylene-19-nor-20(S)-1α,25-dihydroxyvitamin D3 to increase the life expectancy of human beings

(22E)-2-methylene-22-dehydro-1α,24,25-trihydroxy-19-nor-vitamin D3 analogs

2-methylene-(20S,25S)-19,26-dinor-vitamin D analogs

1α-hydroxy-2-(3′-hydroxypropylidene)-19-nor-vitamin D compounds with a 1,1-dimethylpropyl side chain

2-methylene-(22E)-25-(1-methylene-hexyl)-26,27-cyclo-22-dehydro-19-nor-vitamin D analogs

2-methylene-19,26,27-trinor-(20S)-1α-hydroxyvitamin D3 and its uses

DELUCA HECTOR F

Once-a-week administration of 25-hydroxy vitamin D3 to sustain elevated steady-state pharmacokinetic blood concentration

Methods for reducing body fat using vitamin D compounds

Diastereomers of 2-methylene-19-nor-22-methyl-1α,25-dihydroxyvitamin D3

2-substituted-1α,25-dihydroxy-19,26,27-trinor vitamin D analogs and uses thereof

(20R)-2α-methyl-19,26,2-trinor-vitamin D analogs

2α-methyl-19-nor-(20S)-1α-hydroxy-bishomopregnacalciferol and its uses

WISCONSIN ALUMNI RES FOUDATION

1 α-hydroxy-2-methylene-19-nor-pregnacalciferol and its uses

WISCONSIN ALUMI RES FOUNDATION

2α-methyl-19-nor-(20S)-1α-hydroxy-bishomopregnacalciferol and its uses